会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 44. 发明授权
    • B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
    • B.炭疽预防和治疗:突变体B.炭疽菌缺乏勒克斯活性和呋喃酮抑制生长,AI-2群体感应和毒素生产
    • US07955596B2
    • 2011-06-07
    • US12044135
    • 2008-03-07
    • Marcus B. JonesMartin J. BlaserThomas WoodDacheng Ren
    • Marcus B. JonesMartin J. BlaserThomas WoodDacheng Ren
    • A01N63/00A61K39/00A61K39/02C12N1/12C12N15/74C12N15/75
    • C07K14/32
    • The present invention pertains to the discovery that B. anthracis possesses a luxS gene that encodes a functional LuxS polypeptide, and that B. anthracis synthesizes a functional AI-2 quorum-sensing molecule. The invention provides mutant B. anthracis bacteria lacking the function of the luxS gene, which do not produce a functional AI-2 molecule and have growth defects compared to wild-type B. anthracis. The invention also concerns methods for inhibiting the growth of B. anthracis, or for preventing or treating B. anthracis infection, by inhibiting the activity of the B. anthracis LuxS polypeptide, or by exposure of the B. anthracis to furanone. In particular, the invention concerns the use of furanone, a compound that inhibits AI-2-mediated quorum-sensing, to inhibit the growth of B. anthracis, to inhibit B. anthracis toxin production, particularly that of protective antigen, and to prevent or treat B. anthracis infection. The invention also provides methods to prevent B. anthracis infection, or enhance an immune response to B. anthracis infection, by administering a vaccine comprising a B. anthracis cell in which the luxS gene is mutated.
    • 本发明涉及炭疽芽孢杆菌具有编码功能性LuxS多肽的luxS基因的发现,并且炭疽杆菌合成功能性的AI-2群体感应分子。 本发明提供了与野生型炭疽芽孢杆菌相比,不产生功能性AI-2分子并具有生长缺陷的缺乏luxS基因功能的突变体B.炭疽杆菌。 本发明还涉及通过抑制炭疽芽孢杆菌LuxS多肽的活性或通过将炭疽杆菌暴露于呋喃酮而抑制炭疽芽孢杆菌生长或预防或治疗炭疽杆菌感染的方法。 特别地,本发明涉及使用呋喃酮(一种抑制AI-2介导的群体感应的化合物)来抑制炭疽芽孢杆菌的生长,抑制炭疽杆菌毒素生产,特别是保护性抗原的产生,并防止 或治疗炭疽杆菌感染。 本发明还提供了通过施用包含luxS基因突变的炭疽杆菌细胞的疫苗来预防炭疽杆菌感染或增强对炭疽杆菌感染的免疫应答的方法。
    • 45. 发明授权
    • Software architecture and system for performing validated clinical studies of pharmaceutical related products
    • 用于执行药物相关产品验证临床研究的软件架构和系统
    • US07669114B2
    • 2010-02-23
    • US11123720
    • 2005-05-06
    • Thomas Wood
    • Thomas Wood
    • G06F17/00H04N7/16H04L9/00
    • G06F17/21G06F19/00G06Q50/24G16H10/20
    • Software, and a master system with hardware and connections, for validated drug clinical studies includes: creating data collection documents with unique identifiers; having operators complete security identification verification before proceeding; having secured operators fill out and sign specified data collection documents; creating permanent records of the preceding; tracking by unique identifiers in a local system; uploading to a central system; independently reviewing filled out signed data collection documents to accept or require clarifications; keeping permanent read only records of all originally filled out and signed documents; making document clarification requests; reviewing each response; assigning new unique identifier links to each version of every revision; iteratively repeating the above until the documents are clean, and storing and tracking every version of every document in the central system; providing a monitor query and document entry history of all changes to all documents to create a secured audit trail.
    • 软件和具有硬件和连接的主系统用于经过验证的药物临床研究,包括:创建具有唯一标识符的数据收集文档; 操作员完成安全识别验证; 确保操作人员填写并签署指定的数据收集文件; 创建上述的永久记录; 在本地系统中跟踪唯一标识符; 上传到中央系统; 独立审查填写签字数据收集文件以接受或要求澄清; 保留所有原始填写和签名文件的永久性只读记录; 提出文件澄清要求; 回顾每一个回应; 为每个版本的每个版本分配新的唯一标识符链接; 反复重复上述操作,直到文件清洁,并存储和跟踪中央系统中每个文档的每个版本; 提供对所有文档的所有更改的监视器查询和文档输入历史记录,以创建安全的审计跟踪。
    • 46. 发明申请
    • Lightweight glass fiber reinforced thermoplastic material
    • 轻质玻璃纤维增​​强热塑性材料
    • US20090011210A1
    • 2009-01-08
    • US12070372
    • 2008-02-15
    • Xiao GaoThomas Arnold EbelingBrian HynesScott DavisThomas WoodJosephus Theorodus Petrus DictusThomas Arnold Ebeling
    • Xiao GaoThomas Arnold EbelingBrian HynesScott DavisThomas WoodJosephus Theorodus Petrus DictusThomas Arnold Ebeling
    • B32B5/00B32B37/00B32B38/00
    • B32B37/206B29C70/504B29K2101/12B29K2105/0845B29K2105/128B29K2995/0077B32B17/04B32B27/12B32B37/185B32B2260/021B32B2260/046B32B2262/101B32B2305/08B32B2307/54B32B2307/546B32B2307/72B32B2309/105B32B2315/085B32B2398/20B32B2553/00B32B2605/003C08J5/043Y10T156/10
    • A glass fiber reinforced thermoplastic sheet material is provided in which certain properties, or combinations of properties, are improved relative to similar comparative sheet materials. The sheet material generally comprises a glass mat or glass fabric fiber reinforced thermoplastic resin in which the thermoplastic resin at least partially impregnates the glass mat or fabric. The thermoplastic sheet material contains about 15 wt. % to about 65 wt. % of the glass mat or fabric based on the weight of the thermoplastic sheet material and has a thickness in the range of about 0.4 mm to about 3.0 mm. By including glass mat or fabric and maintaining the sheet thickness in the aforementioned range, the present invention thermoplastic sheet material exhibits improved flexural and/or tensile strength and modulus properties at reduced basis weight compared to a comparative thermoplastic sheet materials. A method of providing the glass fiber reinforced thermoplastic sheet material having an improved combination of flexural strength and modulus and/or tensile strength and modulus properties is also described, in which a first layer of a first thermoplastic resin, a second layer of a second thermoplastic resin, and a layer of glass mat or glass fabric are provided; the first thermoplastic resin layer, the second thermoplastic resin layer and the glass mat or glass fabric layer are arranged such that the glass mat or glass fabric layer is interposed between the first and second thermoplastic resin layers; and heat and pressure are applied to substantially melt and compress the first thermoplastic resin and/or the second thermoplastic resin and to at least partially impregnate the glass mat or glass fabric layer with the molten first thermoplastic resin and/or the molten second thermoplastic resin.
    • 提供了一种玻璃纤维增​​强的热塑性片材材料,其中相对于类似的比较片材材料,某些特性或性能的组合得到改善。 片材通常包括玻璃毡或玻璃纤维增​​强热塑性树脂,其中热塑性树脂至少部分地浸渍玻璃毡或织物。 热塑性片材含有约15wt。 %至约65wt。 基于热塑性片材的重量的玻璃毡或织物的百分比,其厚度在约0.4mm至约3.0mm的范围内。 通过包括玻璃毡或织物并将片材厚度保持在上述范围内,与对比的热塑性片材相比,本发明的热塑性片材具有降低的基重的抗弯强度和/或拉伸强度和模量特性。 还描述了提供具有改进的弯曲强度和/或拉伸强度和模量特性的组合的玻璃纤维增​​强热塑性片材的方法,其中第一热塑性树脂第一层,第二热塑性树脂的第二层 树脂和一层玻璃垫或玻璃织物; 第一热塑性树脂层,第二热塑性树脂层和玻璃毡或玻璃织物层被布置成使得玻璃毡或玻璃织物层插入在第一和第二热塑性树脂层之间; 并且施加热和压力以基本上熔化和压缩第一热塑性树脂和/或第二热塑性树脂并且至少部分地用熔融的第一热塑性树脂和/或熔融的第二热塑性树脂浸渍玻璃毡或玻璃织物层。
    • 47. 发明授权
    • B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
    • B.炭疽预防和治疗:突变体B.蒽醌缺乏luxS活性和呋喃酮抑制生长,AI-2群体感应和毒素生产
    • US07365184B2
    • 2008-04-29
    • US10823396
    • 2004-04-12
    • Marcus B. JonesMartin J. BlaserThomas WoodDacheng Ren
    • Marcus B. JonesMartin J. BlaserThomas WoodDacheng Ren
    • C07H21/04C12N15/00C12N21/02C12P21/04C12P21/06
    • C07K14/32
    • The present invention pertains to the discovery that B. anthracis possesses a luxS gene that encodes a functional LuxS polypeptide, and that B. anthracis synthesizes a functional AI-2 quorum-sensing molecule. The invention provides mutant B. anthracis bacteria lacking the function of the luxS gene, which do not produce a functional AI-2 molecule and have growth defects compared to wild-type B. anthracis. The invention also concerns methods for inhibiting the growth of B. anthracis, or for preventing or treating B. anthracis infection, by inhibiting the activity of the B. anthracis LuxS polypeptide, or by exposure of the B. anthracis to furanone. In particular, the invention concerns the use of furanone, a compound that inhibits AI-2-mediated quorum-sensing, to inhibit the growth of B. anthracis, to inhibit B. anthracis toxin production, particularly that of protective antigen, and to prevent or treat B. anthracis infection. The invention also provides methods to prevent B. anthracis infection, or enhance an immune response to B. anthracis infection, by administering a vaccine comprising a B. anthracis cell in which the luxS gene is mutated.
    • 本发明涉及炭疽芽孢杆菌具有编码功能性LuxS多肽的luxS基因的发现,并且炭疽杆菌合成功能性的AI-2群体感应分子。 本发明提供了与野生型炭疽芽孢杆菌相比,不产生功能性AI-2分子并具有生长缺陷的缺乏luxS基因功能的突变体B.炭疽杆菌。 本发明还涉及通过抑制炭疽芽孢杆菌LuxS多肽的活性或通过将炭疽杆菌暴露于呋喃酮而抑制炭疽芽孢杆菌生长或预防或治疗炭疽杆菌感染的方法。 特别地,本发明涉及使用呋喃酮(一种抑制AI-2介导的群体感应的化合物)来抑制炭疽芽孢杆菌的生长,抑制炭疽杆菌毒素生产,特别是保护性抗原的产生,并防止 或治疗炭疽杆菌感染。 本发明还提供了通过施用包含luxS基因突变的炭疽杆菌细胞的疫苗来预防炭疽杆菌感染或增强对炭疽杆菌感染的免疫应答的方法。
    • 50. 发明申请
    • Method and apparatus to protect an ethernet network by suppression of transient voltage pulses using a plasma limiter
    • 通过使用等离子体限制器抑制瞬态电压脉冲来保护以太网网络的方法和装置
    • US20070014069A1
    • 2007-01-18
    • US11474241
    • 2006-06-23
    • Peter KruegerLouie ElliottClifton MurphyThomas WoodRobert Pap
    • Peter KruegerLouie ElliottClifton MurphyThomas WoodRobert Pap
    • H02H9/06
    • H01T19/04H01J17/40
    • The invention described here is a circuit protection device based on the principle of a plasma limiter. A plasma limiter uses an electrode such as a very sharp tungsten needle in an easily ionized gas to perform field enhancement using the interference voltage to initiate avalanche breakdown of the plasma. The gas becomes conductive, causing the interference voltage to short-circuit to ground thereby protecting the transceiver Integrated Circuit (IC). This device protects IC's that can be damaged by voltages greater than about 15 volts when damaging voltages have occurred on the wire(s) for a brief time. The damaging voltage creates an electromagnetic field that is enhanced by the sharp electrode thereby causing the easily ionized gas to become plasma and conduct between the wire and grounded electrode. This conduction prevents the damaging voltage on the wire from becoming so great that IC's become damaged. A protection module consists of devices to protect one or many signals in a single module. An implementation of the protection module is a free-standing module that is placed inline with a cable. Also, an implementation of the protection module is a device to be mounted on the printed circuit board or mounted to a panel of the circuit to be protected.
    • 这里描述的发明是基于等离子体限制器的原理的电路保护装置。 等离子体限制器在容易电离的气体中使用诸如非常锋利的钨针之类的电极,使用干涉电压进行场增强,以引发等离子体的雪崩击穿。 气体导通,导致干扰电压短路到地,从而保护收发器集成电路(IC)。 该器件保护IC在短时间内损坏电线时可能会受到大于15伏的电压的损坏。 损坏的电压产生电磁场,该电磁场被尖锐的电极增强,从而使容易离子化的气体变成等离子体并在导线和接地的电极之间导电。 这种传导可防止线路上的损坏电压变得如此之大,以至于IC损坏。 保护模块由保护单个模块中的一个或多个信号的设备组成。 保护模块的实现是一个独立的模块,与电缆放在一起。 此外,保护模块的实现是要安装在印刷电路板上或者安装到待保护电路的面板上的装置。